A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial. - Wong KH; Day GS; Torner JC; Cudkowicz M; Coffey CS; Cho HJS; Utz U; Clifford DB; Katz E; Ratchford J; Flavin S; Dialino-Felix A; et al. (Neurology open access, 2025)